Focus on treatment of lung carcinoid tumor

por Noel-Savina, Elise, Descourt, Renaud
Publicado 2013

Durvalumab‐induced lesions of bronchiolitis and fully reversible bronchiectasis in a patient with non‐small cell lung cancer: A case report

por Domblides, Maël, Geier, Margaux, Decroisette, Chantal, Descourt, Renaud
Publicado 2021

False Positive 18F-FDG Positron Emission Tomography Findings in Schwannoma—A Caution for Reporting Physicians

por Boré, Paul, Descourt, Renaud, Ollivier, Luc, Le Roux, Pierre-Yves, Abgral, Ronan
Publicado 2018

Henoch–Schönlein Purpura Associated with Lung Cancer: When Paraneoplastic Manifestations Impede Oncological Management

por Philippe, Éloïse, Barnier, Aude, Menguy, Juliette, Robinet, Gilles, Quéré, Gilles, Couturaud, Francis, Descourt, Renaud
Publicado 2021

Case Report: Coronaro-bronchial fistula vascularizing a squamous cell lung cancer

por Ntshaykolo, Chloe, Fave, Thomas, Benic, Clement, Boizet, Antoine, Geier, Margaux, Nicol, Pierre-Philippe, Descourt, Renaud
Publicado 2023

Vascular Acrosyndromes Associated With Prolonged Tumor Response in Advanced Lung Cancer Patients During Treatment With Antimetabolites: A Report of Two Cases

por Geier, Margaux, Babey, Hélène, Monceau-Baroux, Lucie, Quéré, Gilles, Descourt, Renaud, Cornec, Divi, Robinet, Gilles
Publicado 2021

Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer

por Quéré, Gilles, Descourt, Renaud, Robinet, Gilles, Autret, Sandrine, Raguenes, Odile, Fercot, Brigitte, Alemany, Pierre, Uguen, Arnaud, Férec, Claude, Quintin-Roué, Isabelle, Le Gac, Gérald
Publicado 2016

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study)

por Corre, Romain, Gervais, Radj, Guisier, Florian, Tassy, Louis, Vinas, Florent, Lamy, Régine, Fraboulet, Gislaine, Greillier, Laurent, Doubre, Helene, Descourt, Renaud, Chouaid, Christos, Auliac, Jean-Bernard
Publicado 2018

Pembrolizumab plus pemetrexed-carboplatin combination in first-line treatment of advanced non-squamous non-small cell lung cancer: a multicenter real-life study (CAP29)

por Renaud, Emmanuelle, Ricordel, Charles, Corre, Romain, Leveiller, Guillaume, Gadby, Florence, Babey, Hélène, Annic, Josselin, Lucia, François, Bourbonne, Vincent, Robinet, Gilles, Descourt, Renaud, Orione, Charles, Quéré, Gilles, Geier, Margaux
Publicado 2023

Real‐life second‐line epirubicin–paclitaxel regimen as treatment of relapsed small‐cell lung cancer: EpiTax study

por Annic, Josselin, Babey, Hélène, Corre, Romain, Descourt, Renaud, Quéré, Gilles, Renaud, Emmanuelle, Lambert, Mickaël, Le Noac'h, Pierre, Dhamelincourt, Estelle, Nguyen, Jessica, Vu, Alicia, Bourbonne, Vincent, Robinet, Gilles, Geier, Margaux
Publicado 2022

Duration of nivolumab for pretreated, advanced non–small‐cell lung cancer

por Geier, Margaux, Descourt, Renaud, Corre, Romain, Léveiller, Guillaume, Lamy, Régine, Goarant, Éric, Bizec, Jean‐Louis, Bernier, Cyril, Quéré, Gilles, Amrane, Karim, Gaye, Elisabeth, Lucia, François, Burte, Emilie, Chouaid, Christos, Robinet, Gilles
Publicado 2020

First‐line pembrolizumab for non–small cell lung cancer patients with PD‐L1 ≥50% in a multicenter real‐life cohort: The PEMBREIZH study

por Amrane, Karim, Geier, Margaux, Corre, Romain, Léna, Hervé, Léveiller, Guillaume, Gadby, Florence, Lamy, Régine, Bizec, Jean‐Louis, Goarant, Eric, Robinet, Gilles, Gouva, Sylvie, Quere, Gilles, Abgral, Ronan, Schick, Ulrike, Bernier, Cyril, Chouaid, Christos, Descourt, Renaud
Publicado 2020

Brigatinib for Pretreated, ALK-Positive, Advanced Non-Small-Cell Lung Cancers: Long-Term Follow-Up and Focus on Post-Brigatinib Lorlatinib Efficacy in the Multicenter, Real-World B...

por Descourt, Renaud, Pérol, Maurice, Rousseau-Bussac, Gaëlle, Planchard, David, Mennecier, Bertrand, Wislez, Marie, Cadranel, Jacques, Cortot, Alexis Benjamin, Guisier, Florian, Galland, Loïck, Do, Pascal, Schott, Roland, Dansin, Éric, Arrondeau, Jennifer, Auliac, Jean-Bernard, Geier, Margaux, Chouaïd, Christos
Publicado 2022

Paclitaxel–bevacizumab combination in advanced non-squamous non-small-cell lung cancer (NSCLC): AVATAX, a retrospective multicentric study

por Bilger, Geoffroy, Toffart, Anne-Claire, Darrason, Marie, Duruisseaux, Michaël, Ulmer, Lucie, Wang, Pascal, Leprieur, Etienne Giroux, Girard, Nicolas, Massiani, Marie Ange, Bore, Paul, Descourt, Renaud, Pinsolle, Julian, Valery, Solene, Monnet, Isabelle, Swalduz, Aurélie, Tissot, Claire, Fournel, Pierre, Baranzelli, Anne, Cortot, Alexis B., Decroisette, Chantal
Publicado 2022

Overall survival with crizotinib and next-generation ALK inhibitors in ALK-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

por Duruisseaux, Michaël, Besse, Benjamin, Cadranel, Jacques, Pérol, Maurice, Mennecier, Bertrand, Bigay-Game, Laurence, Descourt, Renaud, Dansin, Eric, Audigier-Valette, Clarisse, Moreau, Lionel, Hureaux, José, Veillon, Remi, Otto, Josiane, Madroszyk-Flandin, Anne, Cortot, Alexis, Guichard, François, Boudou-Rouquette, Pascaline, Langlais, Alexandra, Missy, Pascale, Morin, Franck, Moro-Sibilot, Denis
Publicado 2017